Pilot Efficacy Study of T2000 in Myoclonus Dystonia

Status:
Terminated

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

This pilot study will evaluate the safety and efficacy of once daily T2000 when used to treat patients with Myoclonus Dystonia over a 12 week period.

Phase 2

Taro Pharmaceuticals USA